Table 1 Characteristics of patients with SAH
Variables | Total (n = 1481) | ePWV levels | P | ||
|---|---|---|---|---|---|
< 10.12 (n = 879) | [10.12–12.10) (n = 303) | ≥ 12.10 (n = 299) | |||
Age, years, Mean ± SD | 60.16 ± 14.99 | 51.00 ± 10.56 | 67.99 ± 7.26 | 79.17 ± 7.84 | < 0.001 |
Gender, n (%) | Â | Â | Â | Â | 0.825 |
 Female | 824 (55.64) | 484 (55.06) | 173 (57.10) | 167 (55.85) |  |
 Male | 657 (44.36) | 395 (44.94) | 130 (42.90) | 132 (44.15) |  |
Race, n (%) | Â | Â | Â | Â | 0.854 |
 White | 929 (62.73) | 546 (62.12) | 193 (63.70) | 190 (63.55) |  |
 Black | 121 (8.17) | 76 (8.65) | 25 (8.25) | 20 (6.69) |  |
 Others | 431 (29.10) | 257 (29.24) | 85 (28.05) | 89 (29.77) |  |
ICU types, n (%) | Â | Â | Â | Â | 0.019 |
 SICU | 822 (55.50) | 519 (59.04) | 149 (49.17) | 154 (51.51) |  |
 MICU | 126 (8.51) | 66 (7.51) | 32 (10.56) | 28 (9.36) |  |
 Other | 533 (35.99) | 294 (33.45) | 122 (40.26) | 117 (39.13) |  |
HF, n (%) |  |  |  |  | < 0.001 |
 No | 1299 (87.71) | 813 (92.49) | 266 (87.79) | 220 (73.58) |  |
 Yes | 182 (12.29) | 66 (7.51) | 37 (12.21) | 79 (26.42) |  |
AF, n (%) |  |  |  |  | < 0.001 |
 No | 1375 (92.84) | 845 (96.13) | 275 (90.76) | 255 (85.28) |  |
 Yes | 106 (7.16) | 34 (3.87) | 28 (9.24) | 44 (14.72) |  |
RF, n (%) | Â | Â | Â | Â | 0.123 |
 No | 1343 (90.68) | 803 (91.35) | 278 (91.75) | 262 (87.63) |  |
 Yes | 138 (9.32) | 76 (8.65) | 25 (8.25) | 37 (12.37) |  |
Hepatic diseases, n (%) | Â | Â | Â | Â | 0.006 |
 No | 1402 (94.67) | 819 (93.17) | 291 (96.04) | 292 (97.66) |  |
 Yes | 79 (5.33) | 60 (6.83) | 12 (3.96) | 7 (2.34) |  |
COPD, n (%) |  |  |  |  | < 0.001 |
 No | 1348 (91.02) | 824 (93.74) | 261 (86.14) | 263 (87.96) |  |
 Yes | 133 (8.98) | 55 (6.26) | 42 (13.86) | 36 (12.04) |  |
Sepsis, n (%) | Â | Â | Â | Â | 0.096 |
 No | 963 (65.02) | 591 (67.24) | 186 (61.39) | 186 (62.21) |  |
 Yes | 518 (34.98) | 288 (32.76) | 117 (38.61) | 113 (37.79) |  |
Hypertension, n (%) |  |  |  |  | < 0.001 |
 No | 685 (46.25) | 504 (57.34) | 111 (36.63) | 70 (23.41) |  |
 Yes | 796 (53.75) | 375 (42.66) | 192 (63.37) | 229 (76.59) |  |
DM, n (%) |  |  |  |  | < 0.001 |
 No | 1335 (90.14) | 817 (92.95) | 264 (87.13) | 254 (84.95) |  |
 Yes | 146 (9.86) | 62 (7.05) | 39 (12.87) | 45 (15.05) |  |
Malignancy, n (%) | Â | Â | Â | Â | 0.026 |
 No | 1425 (96.22) | 854 (97.16) | 284 (93.73) | 287 (95.99) |  |
 Yes | 56 (3.78) | 25 (2.84) | 19 (6.27) | 12 (4.01) |  |
HR, bpm, Mean ± SD | 80.68 ± 17.70 | 80.64 ± 17.40 | 80.29 ± 17.69 | 81.20 ± 18.61 | 0.814 |
SBP, mmHg, Mean ± SD | 133.84 ± 23.40 | 126.34 ± 20.31 | 140.54 ± 20.58 | 149.12 ± 25.09 | < 0.001 |
DBP, mmHg, Mean ± SD | 70.99 ± 16.29 | 69.06 ± 13.72 | 71.72 ± 16.66 | 75.90 ± 21.11 | < 0.001 |
RR, bpm, Mean ± SD | 17.74 ± 5.05 | 17.72 ± 5.11 | 17.94 ± 5.08 | 17.57 ± 4.83 | 0.658 |
Temperature, ℃, Mean ± SD | 36.76 ± 0.83 | 36.79 ± 0.81 | 36.77 ± 0.80 | 36.64 ± 0.91 | 0.032 |
SOFA, M (Q1, Q3) | 1.00 (0.00, 2.00) | 1.00 (0.00, 2.00) | 1.00 (0.00, 2.00) | 1.00 (0.00, 2.00) | < 0.001 |
WBC, K/µL, Mean ± SD | 13.32 ± 3.76 | 13.32 ± 3.57 | 13.43 ± 4.26 | 13.20 ± 3.77 | 0.751 |
RDW, M (Q1, Q3) | 158.00 (13.80, 227.00) | 160.00 (13.60, 234.00) | 152.00 (13.80, 222.00) | 160.00 (14.40, 220.00) | 0.856 |
Platelet, K/µL, M (Q1, Q3) | 41.10 (35.40, 206.00) | 41.30 (35.90, 213.00) | 40.90 (35.90, 199.00) | 39.60 (33.90, 195.00) | 0.105 |
Hematocrit, M (Q1, Q3) | 13.90 (11.80, 33.60) | 14.00 (11.90, 33.70) | 13.80 (11.90, 34.00) | 13.00 (11.30, 32.40) | 0.014 |
Cr, mg/dL, M (Q1, Q3) | 105.00 (0.90, 138.00) | 102.00 (0.80, 134.00) | 107.00 (0.90, 150.00) | 109.00 (1.00, 139.00) | 0.014 |
Bicarbonate, mEq/L, M (Q1, Q3) | 136.00 (25.00, 140.00) | 136.00 (24.00, 140.00) | 136.00 (25.00, 141.00) | 136.00 (25.00, 140.00) | 0.195 |
Na, mEq/L, M (Q1, Q3) | 4.30 (3.80, 138.00) | 4.30 (3.80, 138.00) | 4.30 (3.80, 138.00) | 4.30 (3.70, 138.00) | 0.994 |
K, mEq/L, M (Q1, Q3) | 101.00 (4.00, 106.00) | 101.00 (4.00, 106.00) | 101.00 (4.00, 106.00) | 100.00 (4.10, 105.00) | 0.869 |
Chloride, mEq/L, M (Q1, Q3) | 9.00 (8.30, 104.00) | 9.00 (8.20, 105.00) | 9.00 (8.30, 104.00) | 9.10 (8.40, 103.00) | 0.931 |
Ca, mg/dL, M (Q1, Q3) | 9.00 (7.90, 12.40) | 9.00 (7.80, 12.80) | 9.10 (8.00, 12.30) | 9.10 (8.00, 12.00) | 0.764 |
SPO2, M (Q1, Q3) | 33.10 (27.00, 98.00) | 32.80 (27.00, 98.00) | 33.90 (27.00, 98.00) | 32.10 (26.70, 98.00) | 0.891 |
Urine output, mL, M (Q1, Q3) | 2050.00 (1502.00, 2940.00) | 2267.00 (1690.00, 3160.00) | 1900.00 (1162.00, 2700.00) | 1700.00 (1250.00, 2375.00) | < 0.001 |
Mechanical ventilation use, n (%) | Â | Â | Â | Â | 0.070 |
 No | 569 (38.42) | 354 (40.27) | 117 (38.61) | 98 (32.78) |  |
 Yes | 912 (61.58) | 525 (59.73) | 186 (61.39) | 201 (67.22) |  |
Vasopressor use, n (%) | Â | Â | Â | Â | 0.792 |
 No | 1207 (81.50) | 714 (81.23) | 251 (82.84) | 242 (80.94) |  |
 Yes | 274 (18.50) | 165 (18.77) | 52 (17.16) | 57 (19.06) |  |
RRT, n (%) | Â | Â | Â | Â | 0.031 |
 No | 1462 (98.72) | 862 (98.07) | 302 (99.67) | 298 (99.67) |  |
 Yes | 19 (1.28) | 17 (1.93) | 1 (0.33) | 1 (0.33) |  |
Clipping of aneurysm, n (%) | Â | Â | Â | Â | 0.095 |
 No | 1406 (94.94) | 826 (93.97) | 290 (95.71) | 290 (96.99) |  |
 Yes | 75 (5.06) | 53 (6.03) | 13 (4.29) | 9 (3.01) |  |
Endovascular coil occlusion, n (%) | Â | Â | Â | Â | 0.636 |
 No | 1429 (96.49) | 849 (96.59) | 294 (97.03) | 286 (95.65) |  |
 Yes | 52 (3.51) | 30 (3.41) | 9 (2.97) | 13 (4.35) |  |
30-day mortality, n (%) |  |  |  |  | < 0.001 |
 No | 1142 (77.11) | 739 (84.07) | 233 (76.90) | 170 (56.86) |  |
 Yes | 339 (22.89) | 140 (15.93) | 70 (23.10) | 129 (43.14) |  |
1-year mortality, n (%) |  |  |  |  | < 0.001 |
 No | 1046 (70.63) | 712 (81.00) | 203 (67.00) | 131 (43.81) |  |
 Yes | 435 (29.37) | 167 (19.00) | 100 (33.00) | 168 (56.19) |  |